Celldex Therapeutics Continues to Stretch Out Its Cash and Advance Its Pipeline
The clinical-stage biotech effectively conserved cash in the first quarter, thanks to cost cuts following last year's pipeline setback with experimental cancer drug glemba.
via FOX BUSINESS NEWS https://fxn.ws/2Wv2o3L
No comments:
Post a Comment